-
-
-
-
-
-
-
Aurinia defends LUPKYNIS after FDA official retracts LinkedIn post
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Announces Board Changes
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

